Topline data were announced from a phase 3 trial evaluating orforglipron in adults with T2D and inadequate glycemic control with diet and exercise alone.

The FDA has updated the labeling for Camzyos to reduce echocardiogram monitoring requirements for patients in the maintenance phase and contraindications.

More than 35% of Americans reported they could not access quality health care if they needed it, the highest number recorded since tracking began in 2021.

Researchers identified 17 risk factors for stroke, dementia, and late-life depression including alcohol, blood pressure, BMI, and fasting plasma glucose.

Neurophobia among Hispanic medical students may deter them from choosing neurology, potentially leading to a future shortage of neurologists.

Compared with CABG, PCI is associated with decreased perioperative complication risks in patients with NSTE-ACS who are renal transplant recipients.

A study has found that food insecurity is an independent predictor for incident cardiovascular disease in the United States.

Hypertension-related vascular dementia mortality rates have increased over the past 15 years, especially among Black and African American individuals.

When applied to cardiac implantable electronic devices, commercially available handheld electro-shockers pose a relevant risk for interaction.

Women and racial-ethnic minorities remain underrepresented in academic neurology, especially in higher ranks and leadership positions.

Low LDL-C levels are associated with a reduced risk for dementia, including Alzheimer disease-related dementia.

Romosozumab vs bisphosphonate use was not linked to increased CVD risks among patients with osteoporosis, challenging past concerns over its cardiovascular safety.